Idaverine, an M2- vs. M3-selective muscarinic antagonist, does not prevent motion sickness in cats
- 31 October 1991
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 40 (2) , 345-349
- https://doi.org/10.1016/0091-3057(91)90565-j
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Functional and binding studies with muscarinic M2‐subtype selective antagonistsBritish Journal of Pharmacology, 1989
- Muscarinic M2 receptors in bovine tracheal smooth muscle: discrepancies between binding and functionEuropean Journal of Pharmacology, 1988
- Distribution of muscarinic cholinergic receptors in the dorsal vagal complex and other selected nuclei in the human medullaBrain Research, 1988
- Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studiesBrain Research, 1986
- Muscarinic cholinergic receptors in area postrema and brainstem areas regulating emesisBrain Research Bulletin, 1985
- Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: BrainstemNeuroscience, 1984
- Comparison of affinities of muscarinic antagonists to pre- and postjunctional receptors in the guinea-pig ileumEuropean Journal of Pharmacology, 1984
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- THE COMPARISON OF PERCENTAGES IN MATCHED SAMPLESBiometrika, 1950